A novel discovery that could lead to the development of more effective treatments for a number of diseases has been made by scientists.
Researchers at NUI Galway have shown that a protein produced when cells are stressed interacts with a stress sensor allowing cells to survive conditions of intense stress.
Endometrial Cancer
Cancer of the Endometrium, or the inner lining of the uterus (womb) is called endometrial cancer.
Advertisement
Understanding this interaction may help scientists interfere with cancer cells so the cells can no longer survive exposure to stressful conditions.
Healthy cells are not usually under stress, but unhealthy cells, such as cancer cells, are often under considerable stress because they grow rapidly in places where they are not supposed to grow.
When a cell is under these stressful conditions, the stress protein Hsp70 is activated to help the cell.
Professor Afshin Samali, lead author of the study and head of the Department of Biochemistry at NUI Galway, and his team have discovered that under cell stress conditions Hsp70 interacts with a receptor in the cell, activating survival mechanisms and preventing apoptosis, the normal cell death mechanism.
By understanding more about Hsp70 and the way it functions, scientists can learn how to block its function, allowing unhealthy cells to succumb to stress and die.
This could have significant implications in the development of new cancer drugs, which would block the protein to encourage tumor cell death.
In contrast to diseases where cell death is abundant such as Alzheimer's, Parkinson's Disease, and Diabetes, increasing the levels of Hsp70 could potentially be used to help these cells survive stressful conditions.
"Our results have identified a novel protein-protein interaction that helps cancer cells to survive stressful growth conditions. By interfering with this interaction we hope to develop a new class of anticancer drugs. This work was funded by Science Foundation Ireland and will have a significant impact on cancer research and drug design," Samali stated.
The findings are published in the online, open access journal PLoS Biology.
Source: ANI
Advertisement
When a cell is under these stressful conditions, the stress protein Hsp70 is activated to help the cell.
Professor Afshin Samali, lead author of the study and head of the Department of Biochemistry at NUI Galway, and his team have discovered that under cell stress conditions Hsp70 interacts with a receptor in the cell, activating survival mechanisms and preventing apoptosis, the normal cell death mechanism.
By understanding more about Hsp70 and the way it functions, scientists can learn how to block its function, allowing unhealthy cells to succumb to stress and die.
This could have significant implications in the development of new cancer drugs, which would block the protein to encourage tumor cell death.
In contrast to diseases where cell death is abundant such as Alzheimer's, Parkinson's Disease, and Diabetes, increasing the levels of Hsp70 could potentially be used to help these cells survive stressful conditions.
"Our results have identified a novel protein-protein interaction that helps cancer cells to survive stressful growth conditions. By interfering with this interaction we hope to develop a new class of anticancer drugs. This work was funded by Science Foundation Ireland and will have a significant impact on cancer research and drug design," Samali stated.
The findings are published in the online, open access journal PLoS Biology.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
An antibody treatment helped shrink tumors in some patients with bile duct cancers.